K. Kelnar

发表

The let-7 microRNA represses cell proliferation pathways in human cells.

F. Slack, Charles D. Johnson, A. Esquela-Kerscher, 2007, Cancer research.

Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

A. Roses, Caifu Chen, K. Kelnar, 2008 .

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.

K. Kelnar, D. Brown, J. Wiggins, 2010, Cancer research.

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

K. Kelnar, D. Brown, J. Wiggins, 2011, Nature medicine.

Regression of murine lung tumors by the let-7 microRNA

F. Slack, J. Weidhaas, K. Kelnar, 2009, Oncogene.

miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.

T. Davison, K. Kelnar, D. Ovcharenko, 2011, Experimental hematology.

Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7.

K. Kelnar, D. Brown, A. Vlassov, 2012, Cancer research.

The microRNA miR-34 a inhibits prostate cancer stem cells and metastasis by directly repressing CD 44

K. Kelnar, D. Brown, J. Wiggins, 2010 .

High-throughput RNAi screening in vitro: from cell lines to primary cells.

K. Kelnar, D. Ovcharenko, D. Brown, 2005, RNA.

A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer

F. Slack, K. Kelnar, Jane Zhao, 2014, Oncogene.

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes.

Yusuke Yamamoto, Takahiro Ochiya, Fumitaka Takeshita, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

PDL1 Regulation by p53 via miR-34

G. Calin, K. Kelnar, D. Gomez, 2015, Journal of the National Cancer Institute.

Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway.

Charles D. Johnson, K. Kelnar, D. Ovcharenko, 2007, Cancer research.

Pathway Identify Small RNA Modulators of TRAIL-Induced Apoptosis Genome-Scale MicroRNA and Small Interfering RNA Screens

Charles D. Johnson, K. Kelnar, D. Ovcharenko, 2007 .

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

K. Kelnar, Keunchil Park, A. Brenner, 2020, British Journal of Cancer.

A qRT-PCR Method for Determining the Biodistribution Profile of a miR-34a Mimic.

K. Kelnar, A. Bader, 2015, Methods in molecular biology.

Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44

K. Kelnar, D. Brown, J. Wiggins, 2010, Nature Medicine.

The microRNA miR-34 a inhibits prostate cancer stem cells and metastasis by directly repressing CD 44

K. Kelnar, D. Brown, J. Wiggins, 2010 .

In-Depth Analysis Shows Synergy between Erlotinib and miR-34a

K. Kelnar, Jane Zhao, A. Bader, 2014, PloS one.

Controlling activation of the RNA-dependent protein kinase by siRNAs using site-specific chemical modification

Landon R. Whitby, K. Kelnar, S. Puthenveetil, 2006, Nucleic acids research.

Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7.

K. Kelnar, D. Brown, A. Vlassov, 2012, Cancer research.

A Microsatellite Genetic Linkage Map for Xiphophorus Sequence data from this article have been deposited with the EMBL/GenBank Data Libraries under accession nos. AY258640, AY258896.

K. Kelnar, D. Johnston, R. Walter, 2004, Genetics.

Synergy between next generation EGFR tyrosine kinase inhibitors and miR-34a in the inhibition of non-small cell lung cancer.

K. Kelnar, Jane Zhao, A. Bader, 2017, Lung cancer.

Quantification of Therapeutic miRNA Mimics in Whole Blood from Nonhuman Primates

K. Kelnar, A. Bader, Heidi J. Peltier, 2014, Analytical chemistry.

O3-02-07: Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways

A. Roses, Caifu Chen, K. Kelnar, 2008, Alzheimer's & Dementia.

Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44

K. Kelnar, D. Brown, J. Wiggins, 2010, Nature Medicine.

Effects of MRX34, a liposomal miR-34 mimic, on target gene expression in human white blood cells (hWBCs): qRT-PCR results from a first-in-human trial of microRNA cancer therapy

K. Kelnar, A. Bader, Heidi J. Peltier, 2016 .

Effects of MRX34, a liposomal miR-34 mimic, on target gene expression in human white blood cells (hWBCs): qRT-PCR results from a first-in-human trial of microRNA cancer therapy.

K. Kelnar, A. Bader, Heidi J. Peltier, 2016 .